Annual report
4594.TEDINET S100VZBU
Period2024-04-01 → 2025-03-31
Filed2025-06-19
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 78
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1m | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥72,000 | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥5m | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥15m | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3m | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥1.2bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | −¥1.2bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | −¥1.1bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.2bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.5bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.5bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.7bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥1.1bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥1.2bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | −¥1.2bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | −¥1.2bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | −¥1.5bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥1.5bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥1.7bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.1bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥1.2bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥1.7bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.8bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.7bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥196m | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥251m | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥925m | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥979m | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.6bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥2.5bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥3.5bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥810m | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥810m | at 2025-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2024-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2023-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2022-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥3.3bn | at 2021-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥1.3bn | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.2bn | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.2bn | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.5bn | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.8bn | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥8m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥2m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥18m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥36m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥1.0bn | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥691m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥432m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥569m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-14.12 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-18.21 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-24.9 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-28.55 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-36.14 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥9.98 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥13.52 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥24.6 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥45.4 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥69.1 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 80.6% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.7% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.9% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.5% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.7% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 90,491,300 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 70,741,300 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 62,891,200 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 55,253,100 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 50,817,500 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 24 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 24 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 32 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 38 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 44 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 742
| Item | Context | Value | Unit |
|---|---|---|---|
| Filer name in english | FilingDateInstant | BrightPath Biotherapeutics Co., Ltd | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2024-04-01 | |
| Current period end date | FilingDateInstant | 2025-03-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2025-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2023-04-01 | |
| Comparative period end date | FilingDateInstant | 2024-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2024-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Disclosure of sustainability related financial information (text) | FilingDateInstant | Text · Plus | |
| Reference to other information | FilingDateInstant | Original text (Japanese)第２ 事業の状況 ３ 事業等のリスク (7) 社内体制について ② 情報管理について | |
| Reference to other information2 governance | FilingDateInstant | Original text (Japanese)第４ 提出会社の概況 ４ コーポレート・ガバナンスの状況等 (1) コーポレート・ガバナンスの概要 | |
| Governance (text) | FilingDateInstant | Text · Plus | |
| Risk management (text) | FilingDateInstant | Text · Plus | |
| Strategy (text) | FilingDateInstant | Text · Plus | |
| Policy on development of human resources and internal environment strategy (text) | FilingDateInstant | Text · Plus | |
| Metrics and targets (text) | FilingDateInstant | Text · Plus | |
| Description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics metrics and targets (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Material matters relating to going concern etc business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts (text) | FilingDateInstant | Text · Plus | |
| Research and development activities (text) | FilingDateInstant | Text · Plus | |
| Overview of capital expenditures etc (text) | FilingDateInstant | Text · Plus | |
| Major facilities (text) | FilingDateInstant | Text · Plus | |
| Planned additions retirements etc of facilities (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所グロース市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |